A Pilot Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Pituitary Adenomas

NCT04390802 · clinicaltrials.gov ↗

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Pituitary Adenoma

Interventions

DRUG: 5-aminolevulinic acid

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]